Menu OpenMenu Close
Louise Line Sign-Up
Email Louise
Facebook icon
Twitter icon
YouTube icon
Instagram icon
Font Size DownDefault Font SizeFont Size Up

Congresswoman Louise Slaughter

Representing the 25th District of New York

Pro-Choice Leaders Call on President Trump to Reverse Birth Control Access Rollback

October 26, 2017
Press Release
189 members of Congress express opposition to the administration’s contraception rules

WASHINGTON, DC — Pro-choice leaders in Congress, led by Democratic Leader Nancy Pelosi (D-CA), Pro-Choice Caucus Co-Chairs Diana DeGette (D-CO) and Louise Slaughter (D-NY), and Congresswoman Nita Lowey (D-NY), today called on President Donald J. Trump to reverse his recent moves to limit women's access to birth control. In a letter this morning to top Trump administration officials, 189 members of Congress expressed their opposition to recent rules proposed by the president that roll back the Affordable Care Act’s provision requiring insurers to cover birth control at no cost. If implemented, the president’s recent rules could rip away contraception coverage from millions of women who have access to birth control without out-of-pocket costs under the ACA, forcing women to pay the full cost of their birth control or go without it.

“The White House’s despicable new rules overrule a woman’s right to basic preventative care and then force her to pay the cost,” said Democratic Leader Nancy Pelosi. “It is with great pride that I join so many colleagues in speaking out against the Trump Administration’s immoral assault on a woman’s right to make her own intimidate decisions about her body and family. Every woman has the right to basic preventative health care.”

“Birth control is health care, plain and simple,” the members wrote in their letter. “The Administration’s decision to isolate contraception from other health care benefits discriminates against women by forcing them to pay more for common health care services they need. It also ignores the well-established facts about contraception’s important role in women’s health. The harmful policies in the IFRs also take effect immediately despite the complete absence of an urgent public need justifying the abandonment of traditional notice-and-comment rulemaking.”

Last week, four House leaders on women’s rights introduced a bill to block the president’s recent actions. Congresswomen DeGette and Slaughter, along with Judy Chu (D-CA) and chair of the Democratic Women’s Working Group Lois Frankel (D-FL), authored the Protect Access to Birth Control Act to safeguard this right for every woman in America.

The two interim final rules issued this month allow nearly any employer to be exempt from the requirement to cover birth control and other forms of contraception without cost-sharing. This legislation would treat these rules as though they had never taken effect, thereby securing the right to birth control coverage as guaranteed by the Affordable Care Act. Companion legislation was introduced in the Senate by Senators Patty Murray (D-WA) and Bob Casey (D-PA).

Contraception not only helps women plan families in a medically-safe way, it is also used to treat conditions such as endometriosis and polycystic ovary syndrome.

A copy of the letter is included below and is available online here:

Dear Secretary Mnuchin, Secretary Acosta, and Acting Secretary Hargan:

We write today in strong opposition to two interim final rules (IFRs) released on October 6, 2017, that may leave women across the United States without access to health insurance coverage for birth control. We call on the Administration to rescind these IFRs and restore policies that facilitate access to affordable contraception for millions of women.

Birth control is health care, plain and simple. The Administration’s decision to isolate contraception from other health care benefits discriminates against women by forcing them to pay more for common health care services they need. It also ignores the well-established facts about contraception’s important role in women’s health.  The harmful policies in the IFRs also take effect immediately despite the complete absence of an urgent public need justifying the abandonment of traditional notice-and-comment rulemaking.

Birth control is vital to both the nation’s public health and women’s health care in particular.  It empowers women and their partners to decide when and how to start and grow a family. A few examples of how access to affordable contraception improves women’s health include:

  • It helps ensure healthy spacing between pregnancies, enabling women to avoid the risks that arise by getting pregnant less than 18 months after giving birth. A recent study found that “the most significant health risks are associated with the shortest birth intervals.”
  • It helps prevent poor birth outcomes and poor health conditions for women, including pregnant women. It reduces the risk of premature birth, placental abruption, low birth weight, and pre-eclampsia, among other health conditions.  More than half of all women who take birth control pills rely on them for other medical purposes. Over one million of these women use birth control exclusively for non-contraceptive reasons.
  • It reduces the incidence of unintended pregnancy, and in turn, reduces the need for abortion. For example, the Contraceptive CHOICE Project revealed dramatic declines in unintended pregnancy among at-risk women who were given free contraception and counseling. In addition, a 2016 study found that the rate of unintended pregnancies decreased 18 percent between 2008 and 2011, with larger declines (44 percent) occurring among women aged 15 to 17. The study’s authors say those declines are likely due to increases in overall contraceptive use among women at risk of unintended pregnancy that occurred over the same period. 

The evidence clearly demonstrates that birth control is a public health success story. That’s why Congress embraced contraception as a vital health care benefit for millions of women in the Affordable Care Act (ACA). The ACA requires health plans to cover recommended preventive services for women without cost-sharing. In response to these ACA provisions, HHS commissioned the non-partisan experts at the Institute of Medicine to identify preventive services necessary to protect women’s health and well-being. Those experts recommended coverage of all contraceptive methods approved by the Food and Drug Administration. The recommendations were reviewed and recommended again by the Women’s Preventive Services Initiative, and adopted by Health Resources & Services Administration (HRSA), just last year. Thanks to these protections in the ACA, over 62 million women now have coverage of birth control with no out-of-pocket cost, saving consumers over one billion dollars each year.  

The Administration’s IFRs severely undermine congressional intent under the ACA. The ACA’s fundamental goal is to expand access to affordable insurance that covers a core set of health benefits. Preventive services are singled out in numerous places throughout the law as especially important benefits that must be accessible and affordable. Nevertheless, the IFRs create broad exemptions that virtually any employer, insurance company, or institute of higher education can use to deny contraception coverage. Compliance with existing accommodations, which guarantee women access to affordable birth control when their employers deny contraception coverage, also becomes optional under the IFRs. And because the accommodation is now optional, many women will have no reasonable way to access birth control coverage.

The IFRs’ impact on women and their families is not hypothetical. These rules threaten to reverse the progress for women’s health, equality, and economic security made under the ACA. Women who lose access to contraception coverage will not only incur higher out-of-pocket costs, they will be forced to pay the full cost of their birth control.  Without insurance coverage, birth control pills can cost as much as $50 per month, with long-acting forms of contraception costing as much as $1,000.  These are not trivial costs for millions of women across the United States. The reality is, for many women, these expenses could put the birth control they need out of reach. Ironically, the IFRs claim that low-income women should be able to access affordable contraception through other government programs, such as Title X and Medicaid, even though the Trump Administration and Congressional Republicans have worked tirelessly to undermine and dismantle these programs.

Employers and insurance companies should not have effective veto power over women’s access to birth control coverage. We certainly agree that religious liberty is a fundamental value protected by the First Amendment. However, it does not give employers the right to discriminate and impose their beliefs on others, especially in a manner that causes harm to health, well-being, and financial security. Contraception should be treated like any other preventive health care benefit under the ACA, which remains the law of the land.

Rather than taking yet another harmful action to undermine health care access for women, we ask that the Administration rescind these misguided IFRs. Instead, the Administration should engage in an open and transparent process with all the key stakeholders prior to changing current law.